Login / Signup

Progression-Free Survival Efficacy in Refractory/Relapsed Multiple Myeloma among Elderly Patients: A Systematic Review.

Tung-Lung YangChin LinChing-Liang HoTzu-Chuan HuangYi-Ying WuHong-Jie JhouPo-Huang ChenCho-Hao Lee
Published in: Life (Basel, Switzerland) (2023)
Our analysis suggests that, pending more comprehensive RCTs, DaraLenDex is the treatment with the highest efficacy for R/R MM in elderly patients.
Keyphrases
  • multiple myeloma
  • free survival
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • combination therapy